Hyaluronan-mediated motility receptor

From WikiMD's WELLNESSPEDIA

Hyaluronan-mediated motility receptor (HMMR), also known as RHAMM (Receptor for Hyaluronan Mediated Motility), is a protein that in humans is encoded by the HMMR gene. This protein is involved in cell motility, and is implicated in various processes such as cell migration, proliferation, and differentiation.

Structure[edit]

The HMMR gene is located on the short (p) arm of chromosome 5 at position 33.2. The protein encoded by this gene is approximately 85 kDa in size and is composed of 777 amino acids. The protein has a central coiled-coil domain and two hyaluronan-binding motifs (HABMs) at the N- and C-termini.

Function[edit]

HMMR is a non-integral cell surface protein that is involved in cell motility. It interacts with hyaluronan, a major component of the extracellular matrix, and plays a crucial role in cell migration, proliferation, and differentiation. HMMR is also involved in the regulation of mitotic spindle assembly and chromosome segregation during cell division.

Clinical significance[edit]

Alterations in the expression of HMMR have been associated with various types of cancer, including breast, colorectal, and lung cancers. Overexpression of HMMR has been shown to promote tumor growth and metastasis. In addition, HMMR has been identified as a potential therapeutic target for cancer treatment.

See also[edit]

References[edit]


External links[edit]

  • HMMR at the National Center for Biotechnology Information (NCBI)


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.